221 related articles for article (PubMed ID: 24093094)
1. PDZ domains and viral infection: versatile potentials of HPV-PDZ interactions in relation to malignancy.
Nagasaka K; Kawana K; Osuga Y; Fujii T
Biomed Res Int; 2013; 2013():369712. PubMed ID: 24093094
[TBL] [Abstract][Full Text] [Related]
2. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance.
Nicolaides L; Davy C; Raj K; Kranjec C; Banks L; Doorbar J
Virology; 2011 Jun; 414(2):137-45. PubMed ID: 21489588
[TBL] [Abstract][Full Text] [Related]
4. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of a phospho-acceptor site enhances HPV E6 PDZ-binding motif functional promiscuity.
Sarabia-Vega V; Banks L
J Gen Virol; 2020 Sep; 101(9):954-962. PubMed ID: 30810519
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein.
Liu Y; Henry GD; Hegde RS; Baleja JD
Biochemistry; 2007 Sep; 46(38):10864-74. PubMed ID: 17713926
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.
Mischo A; Ohlenschläger O; Hortschansky P; Ramachandran R; Görlach M
PLoS One; 2013; 8(4):e62584. PubMed ID: 23638119
[TBL] [Abstract][Full Text] [Related]
8. Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes.
Yoshimatsu Y; Nakahara T; Tanaka K; Inagawa Y; Narisawa-Saito M; Yugawa T; Ohno SI; Fujita M; Nakagama H; Kiyono T
Cancer Sci; 2017 Jul; 108(7):1303-1309. PubMed ID: 28440909
[TBL] [Abstract][Full Text] [Related]
9. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
[TBL] [Abstract][Full Text] [Related]
10. A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.
Kranjec C; Banks L
J Virol; 2011 Feb; 85(4):1757-64. PubMed ID: 21123374
[TBL] [Abstract][Full Text] [Related]
11. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.
Drews CM; Case S; Vande Pol SB
PLoS Pathog; 2019 Apr; 15(4):e1007575. PubMed ID: 31002735
[TBL] [Abstract][Full Text] [Related]
12. Roles of the PDZ domain-binding motif of the human papillomavirus type 16 E6 on the immortalization and differentiation of primary human foreskin keratinocytes.
Choi M; Lee S; Choi T; Lee C
Virus Genes; 2014 Apr; 48(2):224-32. PubMed ID: 24293186
[TBL] [Abstract][Full Text] [Related]
13. Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates.
Thomas M; Dasgupta J; Zhang Y; Chen X; Banks L
Virology; 2008 Jul; 376(2):371-8. PubMed ID: 18452965
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.
Ramirez J; Poirson J; Foltz C; Chebaro Y; Schrapp M; Meyer A; Bonetta A; Forster A; Jacob Y; Masson M; Deryckère F; Travé G
Angew Chem Int Ed Engl; 2015 Jun; 54(27):7958-62. PubMed ID: 26014966
[TBL] [Abstract][Full Text] [Related]
15. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.
Nakagawa S; Huibregtse JM
Mol Cell Biol; 2000 Nov; 20(21):8244-53. PubMed ID: 11027293
[TBL] [Abstract][Full Text] [Related]
16. Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.
Kranjec C; Massimi P; Banks L
J Virol; 2014 Jul; 88(13):7155-69. PubMed ID: 24696483
[TBL] [Abstract][Full Text] [Related]
17. An internal class III PDZ binding motif in HPV16 E6* protein is required for Dlg degradation activity.
Umnajvijit W; Sangthong J; Loison F; Vaeteewoottacharn K; Ponglikitmongkol M
Biochim Biophys Acta Gen Subj; 2021 May; 1865(5):129850. PubMed ID: 33486056
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6.
Kühne C; Gardiol D; Guarnaccia C; Amenitsch H; Banks L
Oncogene; 2000 Nov; 19(51):5884-91. PubMed ID: 11127819
[TBL] [Abstract][Full Text] [Related]
19. Papillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal human papillomavirus genome maintenance.
Brimer N; Vande Pol SB
J Virol; 2014 Mar; 88(5):3027-30. PubMed ID: 24352452
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the Human Papillomavirus E6 Oncoprotein with Sorting Nexin 27 Modulates Endocytic Cargo Transport Pathways.
Ganti K; Massimi P; Manzo-Merino J; Tomaić V; Pim D; Playford MP; Lizano M; Roberts S; Kranjec C; Doorbar J; Banks L
PLoS Pathog; 2016 Sep; 12(9):e1005854. PubMed ID: 27649450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]